Jianmin Pharmaceutical Group Co.,Ltd. (SHA:600976)
China flag China · Delayed Price · Currency is CNY
33.83
-0.81 (-2.34%)
Apr 9, 2026, 3:00 PM CST

SHA:600976 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
113.71163.17305.12219.33301.66
Short-Term Investments
136.51----
Trading Asset Securities
954.14954.19694.46641.38538.63
Cash & Short-Term Investments
1,2041,117999.58860.71840.28
Cash Growth
7.79%11.78%16.13%2.43%45.64%
Accounts Receivable
1,040957.561,150868.66674.6
Other Receivables
123.825.7631.4349.6421.43
Receivables
1,164983.331,181918.29696.03
Inventory
286.57354.31450.85362.88222.6
Other Current Assets
94.89146.43134.06162.85104.5
Total Current Assets
2,7502,6012,7662,3051,863
Property, Plant & Equipment
698.07595.59450.7417.65396.65
Long-Term Investments
722.3772.18650.42444.94326.85
Goodwill
0.210.210.210.210.21
Other Intangible Assets
27.5328.1928.8731.1632.98
Long-Term Deferred Tax Assets
180.34129.49139.44117.27118.33
Long-Term Deferred Charges
136.33130.78111.2791.6687.64
Other Long-Term Assets
12.1619.7421.1432.5630.01
Total Assets
4,5274,2784,1683,4402,856
Accounts Payable
642.52742.22782.91611.06374.92
Accrued Expenses
716.3574.78724.73620.32592.57
Short-Term Debt
55.05140.979.4522.5245
Current Portion of Leases
5.626.395.127.346.1
Current Income Taxes Payable
104.0552.7466.2349.6871.75
Current Unearned Revenue
36.1961.4341.1982.5237.04
Other Current Liabilities
176.11166.66157.31140.25191.85
Total Current Liabilities
1,7361,7451,8571,5341,319
Long-Term Debt
34.034---
Long-Term Leases
31.0324.4330.2923.4820.37
Long-Term Unearned Revenue
44.4146.5518.6112.1827.72
Long-Term Deferred Tax Liabilities
4.87.25.625.970.84
Total Liabilities
1,8501,8271,9111,5751,368
Common Stock
153.4153.4153.4153.4153.4
Additional Paid-In Capital
522.73523.42520.68509.17421.5
Retained Earnings
1,9801,7581,5801,212931.06
Treasury Stock
---6.76-14.99-25.08
Total Common Equity
2,6562,4352,2481,8601,481
Minority Interest
20.415.038.784.997.04
Shareholders' Equity
2,6772,4502,2561,8651,488
Total Liabilities & Equity
4,5274,2784,1683,4402,856
Total Debt
125.73175.71114.8653.3471.48
Net Cash (Debt)
1,079941.65884.72807.37768.81
Net Cash Growth
14.55%6.44%9.58%5.02%38.07%
Net Cash Per Share
7.106.195.795.305.06
Filing Date Shares Outstanding
153.4153.4153.82152.78151.97
Total Common Shares Outstanding
153.4153.4153.82152.78151.97
Working Capital
1,014856.33908.95771.06544.18
Book Value Per Share
17.3215.8814.6112.179.74
Tangible Book Value
2,6292,4072,2191,8291,448
Tangible Book Value Per Share
17.1415.6914.4211.979.53
Buildings
409.52287.12284.12289.38298.05
Machinery
485.88314.22312.36301.9251.25
Construction In Progress
40.17206.6841.4817.1916.73
Source: S&P Global Market Intelligence. Standard template. Financial Sources.